1. Home
  2. WDFC vs RCUS Comparison

WDFC vs RCUS Comparison

Compare WDFC & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WD-40 Company

WDFC

WD-40 Company

HOLD

Current Price

$236.31

Market Cap

3.2B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.13

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDFC
RCUS
Founded
1953
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
WDFC
RCUS
Price
$236.31
$22.13
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$300.00
$29.20
AVG Volume (30 Days)
128.6K
1.1M
Earning Date
01-01-0001
05-28-2026
Dividend Yield
1.73%
N/A
EPS Growth
30.92
N/A
EPS
1.28
N/A
Revenue
$488,109,000.00
$247,000,000.00
Revenue This Year
$7.14
N/A
Revenue Next Year
$6.02
$57.34
P/E Ratio
$184.83
N/A
Revenue Growth
19.49
N/A
52 Week Low
$175.38
$6.79
52 Week High
$253.48
$26.40

Technical Indicators

Market Signals
Indicator
WDFC
RCUS
Relative Strength Index (RSI) 51.18 54.67
Support Level $235.36 $20.35
Resistance Level $237.33 $24.16
Average True Range (ATR) 7.40 1.28
MACD -1.85 0.38
Stochastic Oscillator 25.54 57.99

Price Performance

Historical Comparison
WDFC
RCUS

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: